An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment

Adoptive cellular therapy with chimeric antigen receptor (CAR) T cells has emerged as a potential novel treatment for various cancers. In this study, we have generated CAR T cells targeting mucin-1 (MUC1), which is an aberrantly glycosylated antigen overexpressed on breast cancer cells. Two differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Khuisangeam, Nattarika, Jewmoung, Sirirut, Thaiwong, Rattapoom, Tudsamran, Suparat, Hirankarn, Nattiya, Suppipat, Koramit, Tawinwung, Supannikar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708373/
https://www.ncbi.nlm.nih.gov/pubmed/36457849
http://dx.doi.org/10.1155/2022/2449373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708373/
https://www.ncbi.nlm.nih.gov/pubmed/36457849
http://dx.doi.org/10.1155/2022/2449373

Ejemplares similares